Efficacy of Admixing Azelastine-Fluticasone into Saline Irrigation versus Saline Alone for Allergic Rhinitis: A Randomized Double-Blind Controlled Trial
Journal of Medicine and Urban Health · 02.10.2026 · e8369
DOI: 10.62691/jmuh.2026.8369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicine and Urban Health, online erschienen am 02.10.2026. Verfasst von Pichamol Ouppaphan und 4 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To determine whether admixing a fixed-dose combination of azelastine hydrochloride and fluticasone propionate (MP-AzeFlu) directly into high-volume saline irrigation provides superior clinical outcomes compared with saline irrigation alone in patients with moderate-to-severe allergic rhinitis (AR).Materials and Methods: Forty adults with moderate-to-severe AR were randomized (1:1) to the admixture or control group in this prospective, double-blind, randomized controlled trial. The admixture group mixed four actuations of MP-AzeFlu with 120 mL of isotonic saline per irrigation session and performed nasal irrigation twice daily (eight actuations per day; 548 µg azelastine and 200 µg fluticasone per session, for daily totals of 1,096 µg azelastine and 400 µg fluticasone). The control group followed an identical protocol with a matched isotonic saline control spray. Efficacy was assessed using the 22-item Sinonasal Outcome Test (SNOT-22), visual analog scale (VAS), Modified Lund–Kennedy endoscopic score, and acoustic rhinometry at baseline and at 2 and 4 weeks.
Results
Both groups demonstrated statistically significant improvements in SNOT-22 and VAS scores from baseline (p < 0.001). However, no statistically significant between-group differences were observed for SNOT-22 (coefficient, 1.06; 95% confidence interval, −2.25 to 4.38; p = 0.529), VAS (coefficient, −0.03; 95% confidence interval, −0.85 to 0.79; p = 0.937), Modified Lund–Kennedy endoscopic score (coefficient, −0.05; 95% confidence interval, −0.30 to 0.20; p = 0.700), or acoustic rhinometry parameters (all p > 0.05). No serious adverse events were reported in either group.
Conclusion
In this trial, MP-AzeFlu admixture did not demonstrate a therapeutic advantage over saline irrigation alone. The lack of additive benefit may possibly be attributable to excessive dilution and insufficient mucosal contact time, although the exact mechanism was not directly evaluated in this study. These findings do not support routine use of this off-label admixture protocol. Further comparative studies are needed to determine the optimal delivery strategy for intranasal therapy.
Zitieren
APA
Ouppaphan, P., Wanichakorntrakul, P., Santheeraphap, A., Wongwatana, P., & Niruntrarat, C. (2026). Efficacy of Admixing Azelastine-Fluticasone into Saline Irrigation versus Saline Alone for Allergic Rhinitis: A Randomized Double-Blind Controlled Trial. Journal of Medicine and Urban Health, e8369. https://doi.org/10.62691/jmuh.2026.8369
Vancouver
Ouppaphan P, Wanichakorntrakul P, Santheeraphap A, Wongwatana P, Niruntrarat C. Efficacy of Admixing Azelastine-Fluticasone into Saline Irrigation versus Saline Alone for Allergic Rhinitis: A Randomized Double-Blind Controlled Trial. Journal of Medicine and Urban Health. 2026:e8369. doi:10.62691/jmuh.2026.8369
BibTeX
@article{Ouppaphan2026,
author = {Ouppaphan, Pichamol and Wanichakorntrakul, Pisit and Santheeraphap, Alina and Wongwatana, Phanuwat and Niruntrarat, Chairat},
title = {Efficacy of Admixing Azelastine-Fluticasone into Saline Irrigation versus Saline Alone for Allergic Rhinitis: A Randomized Double-Blind Controlled Trial},
journal = {Journal of Medicine and Urban Health},
year = {2026},
pages = {e8369},
doi = {10.62691/jmuh.2026.8369}
}
EUVIMED